Streetbeat News

Stock Prices

SPOT

Spotify Technology SA (NYSE:SPOT) reported a strong fiscal first-quarter 2024 with a 20% year-on-year revenue growth to $3.95 billion, surpassing the consensus of $3.85 billion. EPS was $1.05, beating the consensus of $0.70. Goldman Sachs analyst Eric Sheridan maintains a Neutral rating on SPOT with a price target of $277. The positive earnings report and forward-looking commentary, along with improvements in gross and operating margins driven by music and podcast trends, led to a 14.74% increase in SPOT shares to $312.31.

Portfolio Pulse from Anusuya Lahiri

April 23, 2024 | 6:08 pm

IBM

IBM is reportedly close to finalizing a deal to acquire a cloud-software provider, according to the Wall Street Journal. This move is seen as part of IBM's strategy to strengthen its position in the cloud computing market.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 6:07 pm

NFLX

Netflix shares are experiencing an uptick as the market reacts positively to its recent earnings report, indicating a rebound in investor confidence.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 6:04 pm

CART

In the past three months, Maplebear (NASDAQ:CART) received 10 analyst ratings, showing a mix of bullish to bearish sentiments. The average 12-month price target is $41.0, indicating an 18.12% increase from the previous target of $34.71. Analysts have adjusted their ratings and price targets, reflecting their evolving expectations for Maplebear, which operates as Instacart. The company has shown a revenue growth rate of 6.08% as of December 31, 2023, a net margin of 16.56%, and an impressive ROE of 3.68%, despite lagging behind industry peers in revenue growth.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:01 pm

TCRX

TScan Therapeutics (NASDAQ:TCRX) received mixed analyst ratings with an updated average 12-month price target of $10.75, marking a 53.57% increase from the previous target. Analysts from Wedbush, Barclays, and HC Wainwright & Co. have maintained or raised their ratings, reflecting optimism in TCRX's market performance. The company, focusing on T-cell receptor engineered T cell therapies for cancer, shows substantial market capitalization and revenue growth but has a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:01 pm

PNFP

Analyst reviews for Pinnacle Financial Partners (PNFP) show a mix of bullish to bearish sentiments, with recent actions including ratings adjustments and price target changes. The average 12-month price target is $96.5, reflecting a 6.63% increase from the previous $90.50. The company's financial performance indicates challenges in revenue growth and asset utilization but shows strong profitability with a high net margin.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:00 pm

ANIP

ANI Pharmaceuticals (NASDAQ:ANIP) has been positively evaluated by 5 analysts, with recent ratings showing a bullish outlook. The average 12-month price target has been raised to $77.8, indicating a 9.19% increase from the previous target. Analyst actions include maintaining and raising price targets, reflecting optimism about the company's performance. ANI Pharmaceuticals has shown impressive financial performance with significant revenue growth, efficient cost management, and strong financial health, outperforming industry benchmarks.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:00 pm

APLD

Applied Digital (NYSE:APLD) has seen a 9.17% increase in short percent of float, with 21.13 million shares sold short, representing 21.66% of available shares. This indicates a bearish market sentiment towards APLD, as it exceeds the peer group average of 5.66% for short interest as a percentage of float. The data suggests caution, as an increase in short interest can signal market expectations of a price decline, though it can also present bullish opportunities under certain conditions.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:00 pm

NTRA

Natera's (NYSE:NTRA) short interest has decreased by 21.4%, with 6.25 million shares sold short, representing 5.51% of its float. This decline in short interest suggests a more bullish sentiment among investors compared to its peers, where the average short interest is 5.96%. The coverage time for these short positions is approximately 3.85 days based on current trading volumes.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:00 pm

NYCB

New York Community (NYSE:NYCB) has seen a 12.26% increase in its short percent of float since the last report, with 75.57 million shares sold short, representing 10.62% of its available trading shares. This places it above its peer group average of 4.93% in short interest as a percentage of float. The rise in short interest indicates a more bearish market sentiment towards NYCB, although it does not necessarily predict a near-term price fall.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:00 pm